146 related articles for article (PubMed ID: 33073906)
1. To investigate outcomes in endoscopic management of early oesophageal adenocarcinoma in Barrett oesophagus: experience at three Australian tertiary centres.
Pateria P; Chong A; Muwanwella N; Siah C; Kumarasinghe P; Raftopoulos S
Intern Med J; 2022 Apr; 52(4):633-639. PubMed ID: 33073906
[TBL] [Abstract][Full Text] [Related]
2. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
[TBL] [Abstract][Full Text] [Related]
4. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
5. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
6. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue.
Bowman CJ; Zhang R; Balitzer D; Wang D; Rabinovitch PS; Kővári BP; Mattis AN; Kakar S; Lauwers GY; Choi WT
Mod Pathol; 2021 Oct; 34(10):1889-1900. PubMed ID: 34108638
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of endoscopic submucosal dissection (ESD) plus radiofrequency ablation (RFA) for nodular Barrett's esophagus.
Bahdi F; Katti CC; Mansour N; Gagneja H; Anandasabapathy S; Othman MO
Scand J Gastroenterol; 2023 Feb; 58(2):123-132. PubMed ID: 35968576
[TBL] [Abstract][Full Text] [Related]
9. Predictors of recurrence of dysplasia or cancer in patients with dysplastic Barrett's esophagus following complete eradication of dysplasia: a single-center retrospective cohort study.
Kobayashi R; Calo NC; Marcon N; Iwaya Y; Shimamura Y; Honda H; Streutker C; Mosko J; May G; Teshima C
Surg Endosc; 2022 Jul; 36(7):5041-5048. PubMed ID: 34750708
[TBL] [Abstract][Full Text] [Related]
10. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
[TBL] [Abstract][Full Text] [Related]
11. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia.
Kim HP; Bulsiewicz WJ; Cotton CC; Dellon ES; Spacek MB; Chen X; Madanick RD; Pasricha S; Shaheen NJ
Gastrointest Endosc; 2012 Oct; 76(4):733-9. PubMed ID: 22732872
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study.
Wani S; Abrams J; Edmundowicz SA; Gaddam S; Hovis CE; Green D; Gupta N; Higbee A; Bansal A; Rastogi A; Early D; Lightdale CJ; Sharma P
Dig Dis Sci; 2013 Jun; 58(6):1703-9. PubMed ID: 23633158
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience.
Huntington JT; Walker JP; Meara MP; Hazey JW; Melvin WS; Perry KA
Surg Endosc; 2015 Aug; 29(8):2121-5. PubMed ID: 25472745
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological predictors of failure of endoscopic therapy for Barrett's related high-grade dysplasia and early esophageal adenocarcinoma.
Shimamura Y; Iwaya Y; Kobayashi R; Rodriguez de Santiago E; Muwanwella N; Raftopoulos S; Mosko JD; May GR; Kandel G; Kortan P; Marcon N; Teshima CW
Surg Endosc; 2021 Oct; 35(10):5468-5479. PubMed ID: 32989547
[TBL] [Abstract][Full Text] [Related]
17. Evolving changes in the management of early oesophageal adenocarcinoma in a tertiary centre.
O'Farrell NJ; Reynolds JV; Ravi N; Larkin JO; Malik V; Wilson GF; Muldoon C; O'Toole D
Ir J Med Sci; 2013 Sep; 182(3):363-9. PubMed ID: 23242575
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
Al Natour RH; Catanzaro A; Zolotarevsky E; DeBenedet AT; Gunaratnam NT
Dis Esophagus; 2018 Jan; 31(1):1-6. PubMed ID: 29087500
[TBL] [Abstract][Full Text] [Related]
19. Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective.
Sengupta N; Ketwaroo GA; Bak DM; Kedar V; Chuttani R; Berzin TM; Sawhney MS; Pleskow DK
Gastrointest Endosc; 2015 Sep; 82(3):443-8. PubMed ID: 25887715
[TBL] [Abstract][Full Text] [Related]
20. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
